GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

AFC-HD AMS Life Science Co 2927.T · JPY

Consumer Staples · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

831

+0.73%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥34.32bn

FY2017FY2026

Net income

¥1.20bn

FY2017FY2026

Free cash flow

−¥726.4m

FY2017FY2026

Shareholders' equity

¥16.21bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥34.32bn¥32.66bn¥30.19bn¥25.58bn¥23.00bn¥22.37bn¥15.82bn¥16.25bn¥15.80bn¥15.14bn
Gross profit¥11.65bn¥10.97bn¥10.49bn¥9.32bn¥8.58bn¥6.87bn¥4.55bn¥4.52bn¥4.59bn¥4.61bn
Research and development—¥143.1m¥148.0m¥145.1m¥153.0m¥163.7m¥166.4m¥156.6m¥139.2m¥116.1m
Operating income¥2.45bn¥2.38bn¥1.92bn¥1.64bn¥1.02bn¥2.25bn¥1.09bn¥981.3m¥1.02bn¥1.07bn
Net income¥1.20bn¥1.45bn¥1.25bn¥1.10bn¥735.4m¥1.50bn¥676.7m¥783.3m¥736.7m¥465.9m
Diluted earnings per share76.25101.7488.9878.9052.34105.0248.5055.7052.3838.48

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥49.05bn¥48.73bn¥47.03bn¥41.07bn¥37.35bn¥35.75bn¥18.55bn¥18.33bn¥18.01bn¥16.76bn
Cash and short-term investments¥9.76bn¥11.30bn¥12.17bn¥11.18bn¥10.38bn¥9.22bn¥4.73bn¥4.44bn¥4.08bn¥3.39bn
Total liabilities¥32.61bn¥33.53bn¥33.07bn¥27.91bn¥24.90bn¥23.09bn¥8.08bn¥8.22bn¥8.35bn¥9.10bn
Debt¥23.41bn¥24.14bn¥23.40bn¥19.59bn¥17.18bn¥14.77bn¥4.09bn¥4.28bn¥4.25bn¥5.40bn
Shareholders' equity¥16.21bn¥15.08bn¥13.93bn¥13.11bn¥12.44bn¥11.92bn¥10.46bn¥10.11bn¥9.65bn¥7.66bn
Shares outstanding16m14m14m14m14m14m14m14m14m12m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥1.68bn¥1.79bn¥1.54bn¥865.3m¥1.49bn¥2.58bn¥1.30bn¥1.13bn¥1.22bn¥525.6m
Capital spending−¥2.40bn−¥3.54bn−¥3.41bn−¥1.94bn−¥958.0m−¥492.1m−¥381.3m−¥546.8m−¥549.3m−¥851.9m
Free cash flow−¥726.4m−¥1.75bn−¥1.87bn−¥1.07bn¥534.4m¥2.09bn¥917.7m¥585.1m¥672.3m−¥326.3m
Dividends paid−¥514.0m−¥434.4m−¥418.8m−¥385.1m−¥422.0m−¥312.5m−¥350.2m−¥280.1m−¥181.0m−¥181.0m

Latest quarters

By quarter end

Aug 2026May 2026Feb 2026Nov 2025Aug 2025May 2025Feb 2025Nov 2024
Revenue¥9.05bn¥8.43bn¥8.30bn¥8.55bn¥7.92bn¥8.12bn¥8.42bn¥8.19bn
Gross profit¥3.00bn¥2.91bn¥2.78bn¥2.96bn¥2.69bn¥2.77bn¥2.76bn¥2.82bn
Operating income¥654.8m¥549.0m¥479.6m¥771.6m¥556.1m¥558.6m¥644.1m¥650.0m
Net income¥32.6m¥365.4m¥278.4m¥522.6m¥36.1m¥531.0m¥421.3m¥460.0m
Diluted earnings per share2.0723.2417.7136.702.5337.2929.5932.69
Cash from operations————¥1.79bn———
Capital spending————−¥3.54bn———
Free cash flow————−¥1.75bn———
Total assets¥49.05bn¥49.95bn¥50.25bn¥49.15bn¥48.73bn¥48.80bn¥47.75bn¥48.36bn
Cash and short-term investments¥9.76bn¥9.70bn¥11.09bn¥10.60bn¥11.30bn¥11.34bn¥11.37bn¥11.43bn
Debt¥18.80bn¥19.16bn¥23.76bn¥18.51bn¥24.02bn¥10.52bn¥23.74bn¥10.11bn
Shareholders' equity¥16.21bn¥16.15bn¥16.03bn¥15.56bn¥15.08bn¥14.92bn¥14.64bn¥14.20bn

Financial ratios

Data as of 3 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin33.6%34.8%36.4%37.3%30.7%28.8%
Operating margin7.3%6.3%6.4%4.6%10.0%6.9%
Net margin4.4%4.1%4.3%3.2%6.7%4.3%
Return on equity9.6%9.0%8.4%5.9%12.5%6.5%
Return on assets3.0%2.7%2.7%2.0%4.2%3.6%
Free cash flow yield44.4%41.7%23.8%20.7%25.6%14.3%
Revenue growth8.2%18.0%11.2%2.8%41.4%-2.7%
Earnings growth15.7%13.6%49.9%-50.8%121.0%-13.6%
Current ratio0.86x1.25x1.34x1.30x1.34x1.61x
Debt to equity1.59x1.66x1.49x1.38x1.23x0.38x
Equity ratio30.9%29.6%31.9%33.3%33.3%56.4%
Interest coverage11.83x18.92x28.43x18.55x44.87x33.22x
R&D as a share of sales0.4%0.5%0.6%0.7%0.7%1.1%
Buybacks as a share of market value-1.2%-0.7%0.5%1.3%-2.1%0.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue10.3%8.9%8.9%
Operating income14.4%1.7%10.6%
Net income2.8%-4.3%9.4%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin33.8%34.6%34.4%32.8%
Operating margin7.2%6.8%6.9%6.8%
Net margin4.0%4.1%4.3%4.2%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings11.18.79.410.114.48.314.312.112.323.8
Price to sales0.40.40.40.40.50.60.60.60.60.7

Dividends and splits

Per share, in the currency the company pays

Paid for 21 years. Last went ex-dividend on 26 Feb 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year18.0049.0030.0027.5030.0022.5020.0020.00
  • 10-for-1 split · 29 Aug 2011
  • 3-for-1 split · 26 Aug 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.